Search Filters

HTA of the addition of severe combined immunodeficiency (SCID) to the National Newborn Bloodspot Screening Programme

Status: Published on

The National Screening Advisory Committee (NSAC) was established in 2019 by the Minister for Health as an independent advisory committee to play a significant strategic role in the development and consideration of population-based screening programmes in Ireland. At the request of the Department of Health, the Health Technology Assessment (HTA) directorate within the Health Information and Quality Authority (HIQA) undertakes evidence synthesis and provides evidence-based advice to NSAC on behalf of the Minister for Health.

In September 2021, NSAC requested that HIQA undertake a health technology assessment of the potential addition of severe combined immunodeficiency (SCID) to the National Newborn Bloodspot Screening Programme (NNBSP) in Ireland. The protocol document outlines the evidence synthesis approach that HIQA’s evaluation team will use to complete this piece of work.